Increased RANKL levels may cause enhanced osteoclast activity and promote tumor cell invasion [14], consistent with previous studies implicating the RANKL–RANK axis in driving osteolysis during breast cancer metastasis [5,37,38]. Here, TNFRSF11A is linked to breast carcinoma.